A bill for an act relating to a review of anti-obesity medications by the department of health and human services for purposes of the medical assistance program.

HF 701 requires Iowa's Department of Health and Human Services to review anti-obesity medications for potential inclusion in the state's Medicaid program (medical assistance program). The review must assess medication effectiveness, impact on related health conditions (comorbidities), cost savings from avoiding other treatments, and recommended eligibility rules. The department must submit a report with findings and proposed eligibility requirements to the legislature by December 1, 2025. This bill does not change current coverage but sets a process for evaluating these medications for future Medicaid inclusion. It directly affects Medicaid beneficiaries and the state's healthcare spending on obesity-related treatments.